Schedule 13D ownership disclosure
NEWAMSTERDAM PHARMA COMPANY
Security class unavailable · CUSIP: N62509109
Event date: 2023-06-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-23-164408
- Form type
- SC 13D
- Filer
- Frazier Life Sciences X, L.P.
- CIK
- CIK 1790879
- Filed
- Jun 09, 2023
- Reporting period
- Jun 07, 2023
- Description
- Schedule 13D beneficial ownership